Trials / Completed
CompletedNCT03628456
Effect of HFCWO Vests on Spirometry Measurements
Effect of High Frequency Chest Wall Oscillation Vests on Spirometry Measurements, Comparative Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- International Biophysics Corporation · Industry
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The impact of high-frequency chest wall oscillation therapy on spirometry values (Forced Expiratory Volume, Forced Vital Capacity, Peak Expiratory Flow, Forced Expiratory Flow and Tidal Volume is investigated during use of several products and comparing to baseline values
Detailed description
The study will be broken into one (1) arm: • AffloVest® \& Monarch™ Within the arm, the order of products will be randomized. Baseline spirometry (Forced Expiratory Volume (FEV1), Forced Vital Capacity (FVC), Peak Expiratory Flow (PEF), Forced Expiratory Flow (FEF25-75%) and Tidal Volume (TV)) will be taken at the beginning, middle and end of each series of measurements with each subject, without any device on the subject. A product (AffloVest or Monarch) will be placed onto subject and turned ON to the highest frequency and intensity settings. Then the subject will be given a certain period of time to adjust and spirometry measurements will then be repeated, then the product will be removed and the subject will be allowed a recovery period, then the other product will be placed on the subject, turned ON and spirometry measurements will repeated.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | International Biophysics AffloVest | High-frequency chest wall oscillation vest |
| DEVICE | Hill-Rom Monarch | High-frequency chest wall oscillation vest |
Timeline
- Start date
- 2018-09-13
- Primary completion
- 2018-09-21
- Completion
- 2019-07-02
- First posted
- 2018-08-14
- Last updated
- 2019-11-22
- Results posted
- 2019-11-13
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03628456. Inclusion in this directory is not an endorsement.